Polynovo shares soar on type 1 diabetes breakthrough
Investors with a short position in wound care house Polynovo face a 'short squeeze' after type 1 diabetes trial results Oz drug stocks partly recover after swooning yesterday on Trump drug-pricing edict Wellnex Life rediscovers its sales mojo, …